Consistent with these findings, colocalization of phosphorylated Tau and PSD-95 increases during Alzheimer’s disease progression across clinically stratified groups (normal, mild cognitive impairment, Alzheimer’s disease) in the frontal cortex30. The gene discussed is MAPT; the disease is Alzheimer disease.